Foscarbidopa Uses, Dosage, Side Effects and more
Foscarbidopa is under investigation in clinical trial NCT04379050 (Extension Study to Evaluate Safety and Tolerability of 24-hour Daily Exposure of Continuous Subcutaneous Infusion of ABBV-951 in Adult Participants With Parkinson's Disease).
| Trade Name | Foscarbidopa |
| Generic | Foscarbidopa |
| Foscarbidopa Other Names | Foscarbidopa |
| Type | |
| Formula | C10H15N2O7P |
| Weight | Average: 306.211 Monoisotopic: 306.061687829 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
